GC

Gerald R. Crabtree

Stanford University: 29 patents #72 of 5,197Top 2%
Harvard University: 18 patents #61 of 3,600Top 2%
BU Board Of Trustees Leland Stanford Jr University: 10 patents #2 of 153Top 2%
HI Howard Hughes Medical Institute: 2 patents #38 of 128Top 30%
ER Erasmus University Medical Center Rotterdam: 1 patents #63 of 114Top 60%
PF Purdue Research Foundation: 1 patents #1,409 of 3,174Top 45%
SL Sara Lee: 1 patents #108 of 246Top 45%
🗺 California: #9,121 of 386,348 inventorsTop 3%
Overall (All Time): #62,566 of 4,157,543Top 2%
46
Patents All Time

Issued Patents All Time

Showing 1–25 of 46 patents

Patent #TitleCo-InventorsDate
11980613 Methods for reversing HIV latency using BAF complex modulating compounds Emily Carla Dykhuizen, Tokameh Mahmoudi 2024-05-14
11267809 BAF complex modulating compounds and methods of using the same Emma J. Chory, Emily Carla Dykhuizen 2022-03-08
10976320 Methods for identifying and treating cancer patients Emily Carla Dykhuizen, Diana Clare Hargreaves, Cigall Kadoch 2021-04-13
10105420 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma Cigall Kadoch 2018-10-23
9410943 Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma Cigall Kadoch 2016-08-09
8084596 Regulated apoptosis Peter Belshaw, Stuart L. Schreiber, David Spencer, Thomas J. Wandless 2011-12-27
8044099 Synthetic bifunctional molecules containing drug moiety and pharmacokinetic modulating moiety Roger Briesewitz, Thomas J. Wandless 2011-10-25
7923230 Neurodegenerative protein aggregation inhibition methods and compounds Isabella A. Graef, Jason E. Gestwicki 2011-04-12
7498025 Targeted bifunctional molecules and therapies based thereon Roger Briesewitz, Thomas J. Wandless 2009-03-03
7485706 Neurodegenerative protein aggregation inhibition methods and compounds Isabella A. Graef, Jason E. Gestwicki 2009-02-03
7390784 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy Roger Briesewitz, Thomas J. Wandless, Gregory Thomas Ray, Kurt Vogel 2008-06-24
7323439 Methods and compositions for modulating angiogenesis Isabella A. Graef, Feng-Jing Chen 2008-01-29
7220552 Bifunctional molecules and their use in the disruption of protein-protein interactions Kryn Stankunas, Roger Briesewitz, Thomas J. Wandless 2007-05-22
6984635 Dimerizing agents, their production and use Stuart L. Schreiber, Stephen D. Liberles 2006-01-10
6982082 Gene therapy by cell specific targeting Stuart L. Schreiber, Peter Belshaw 2006-01-03
6972193 Regulated transcription of targeted genes and other biological events Stuart L. Schreiber, David Spencer, Thomas J. Wandless, Steffan N. Ho, Peter Belshaw 2005-12-06
6921531 Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy Roger Briesewitz, Thomas J. Wandless, Gregory Thomas Ray, Kurt Vogel 2005-07-26
6891021 Regulated apoptosis Stuart L. Schreiber, David Spencer, Thomas J. Wandless, Peter Belshaw 2005-05-10
6887842 Modulating a pharmacokinetic property of a drug by administering a bifunctional molecule containing the drug Roger Briesewitz, Thomas J. Wandless 2005-05-03
6875571 NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agents Jeffrey P. Northrop, Steffan N. Ho, William Michael Flanagan 2005-04-05
6388052 NF-AT polypeptides and polynucleotides Jeffrey P. Northrop, Steffan N. Ho 2002-05-14
6372712 Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand Roger Briesewitz, Thomas J. Wandless, Gregory Thomas Ray, Kurt Vogel 2002-04-16
6352830 NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agents Jeffrey P. Northrop, Steffan N. Ho, William Michael Flanagan 2002-03-05
6316418 Regulated apoptosis Stuart L. Schreiber, David Spencer, Thomas J. Wandless, Peter Belshaw, Steffan N. Ho 2001-11-13
6312899 NF-AT polypeptides and polynucleotides Jeffrey P. Northrop, Steffan N. Ho 2001-11-06